Revvity, Inc. (RVTY) stock
RVTYNYSELaboratory Analytical InstrumentsFiscal year ends December 29
Financials through Q2 FY2026, quarter ended Jul 5, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3042% above fair value
$147.79−1.06 (-0.71%)
Close on Nov 17, 2026Market cap $16.49BP/E 70.4Yield 0.19%
Revvity total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Revvity's total debt was $3.21B at Jul 5, 2026. For fiscal 2025 it was $3.22B, up 2.2% from the year before. Over ten years it grew 12.3% a year on average. The highest annual figure on record is $4.98B in fiscal 2021.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 28, 2025 | $3.22B | +2.2% |
| FY2024 | Dec 29, 2024 | $3.15B | -19.2% |
| FY2023 | Dec 31, 2023 | $3.90B | -11.3% |
| FY2022 | Jan 1, 2023 | $4.39B | -11.8% |
| FY2021 | Jan 2, 2022 | $4.98B | +150.3% |
| FY2020 | Jan 3, 2021 | $1.99B | -4.0% |
| FY2019 | Dec 29, 2019 | $2.07B | +9.7% |
| FY2018 | Dec 30, 2018 | $1.89B | -5.7% |
| FY2017 | Dec 31, 2017 | $2.01B | +91.7% |
| FY2016 | Jan 1, 2017 | $1.05B | +3.3% |
| FY2015 | Jan 3, 2016 | $1.01B | -3.2% |
| FY2014 | Dec 28, 2014 | $1.05B | +12.0% |
| FY2013 | Dec 29, 2013 | $934.73M | -0.6% |
| FY2012 | Dec 30, 2012 | $940.60M | -0.5% |
| FY2011 | Jan 1, 2012 | $944.91M | +121.7% |
| FY2010 | Jan 2, 2011 | $426.26M | -23.6% |
| FY2009 | Jan 3, 2010 | $558.20M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 5, 2026 | $3.21B | -0.3% |
| Q1 FY2026 | Apr 5, 2026 | $3.21B | +1.2% |
| Q4 FY2025 | Dec 28, 2025 | $3.22B | +2.2% |
| Q3 FY2025 | Sep 28, 2025 | $3.21B | +0.9% |
| Q2 FY2025 | Jun 29, 2025 | $3.21B | -17.0% |
| Q1 FY2025 | Mar 30, 2025 | $3.17B | -18.3% |
| Q4 FY2024 | Dec 29, 2024 | $3.15B | -19.2% |
| Q3 FY2024 | Sep 29, 2024 | $3.19B | -17.9% |
| Q2 FY2024 | Jun 30, 2024 | $3.87B | -11.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.88B | -11.1% |
| Q4 FY2023 | Dec 31, 2023 | $3.90B | -11.3% |
| Q3 FY2023 | Oct 1, 2023 | $3.88B | -11.9% |
| Q2 FY2023 | Jul 2, 2023 | $4.36B | -2.8% |
| Q1 FY2023 | Apr 2, 2023 | $4.36B | -10.4% |
| Q4 FY2022 | Jan 1, 2023 | $4.39B | -11.8% |
| Q3 FY2022 | Oct 2, 2022 | $4.40B | -13.8% |
| Q2 FY2022 | Jul 3, 2022 | $4.49B | +90.7% |
| Q1 FY2022 | Apr 3, 2022 | $4.87B | +88.8% |
| Q4 FY2021 | Jan 2, 2022 | $4.98B | +150.3% |
| Q3 FY2021 | Oct 3, 2021 | $5.10B | +175.4% |
| Q2 FY2021 | Jul 4, 2021 | $2.35B | +19.4% |
| Q1 FY2021 | Apr 4, 2021 | $2.58B | +27.6% |
| Q4 FY2020 | Jan 3, 2021 | $1.99B | -4.0% |
| Q3 FY2020 | Oct 4, 2020 | $1.85B | -17.9% |
| Q2 FY2020 | Jul 5, 2020 | $1.97B | -6.7% |
| Q1 FY2020 | Apr 5, 2020 | $2.02B | +8.5% |
| Q4 FY2019 | Dec 29, 2019 | $2.07B | +9.7% |
| Q3 FY2019 | Sep 29, 2019 | $2.26B | +18.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.11B | +5.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.86B | -10.4% |
| Q4 FY2018 | Dec 30, 2018 | $1.89B | -5.7% |
| Q3 FY2018 | Sep 30, 2018 | $1.90B | +71.3% |
| Q2 FY2018 | Jul 1, 2018 | $2.00B | +83.3% |
| Q1 FY2018 | Apr 1, 2018 | $2.08B | +96.9% |
| Q4 FY2017 | Dec 31, 2017 | $2.01B | +91.7% |
| Q3 FY2017 | Oct 1, 2017 | $1.11B | -2.0% |
| Q2 FY2017 | Jul 2, 2017 | $1.09B | – |
| Q1 FY2017 | Apr 2, 2017 | $1.05B | – |
| Q4 FY2016 | Jan 1, 2017 | $1.05B | – |
| Q3 FY2016 | Oct 2, 2016 | $1.13B | – |
See a number that looks wrong?